Fighting the Swamp and Conflicts of Interest, Truth About DOGE Cuts, and Finding Autism Cause, with FDA Commissioner Dr. Marty Makary | Ep. 1051
Megyn Kelly is joined by FDA Commissioner Dr. Marty Makary for his first interview in his new position to discuss what he's learned since taking over the position 17 days ago, whether there are people in the building who are open to MAHA, what's currently working properly at the agency and what's not, the issues with the VAERS system, recent critiques from Peter Marks who left the agency, the need to ask questions in science and not jump to conclusions, his new policy limiting who can serve as members on FDA advisory committees, his efforts to counter the perception that the FDA has been captured by Big Pharma and other industries, how he learned first-hand about "the swamp," the apolitical work he and RFK are doing, his efforts to get certain drugs approved faster and to limit animal testing, the truth about the DOGE cuts and how no scientists or reviewers were cut, his relationship with RFK, his effort to redo the food pyramid, the efforts by RFK to get to the cause of autism, the need to look at environmental and dietary exposures that could alter the microbiome, and more.
Grand Canyon University: https://GCU.edu
Lean: Visit https://TakeLean.com & use code MK20 for 20% off
Ancient Nutrition: Enjoy 25% off your first order at https://AncientNutrition.com/MEGYN
Follow The Megyn Kelly Show on all social platforms:
YouTube: https://www.youtube.com/MegynKelly
Twitter: http://Twitter.com/MegynKellyShow
Instagram: http://Instagram.com/MegynKellyShow
Facebook: http://Facebook.com/MegynKellyShow
Find out more information at:
https://www.devilmaycaremedia.com/megynkellyshow
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Available Results
Generated results are saved to your library for reuse and search.
Choose Template
Pick the result you want. You can review provider and model before generating.
A concise first-pass summary for understanding the episode quickly.
A comprehensive, source-grounded extraction of the reusable knowledge in an episode.
A comprehensive extraction focused on health practices, protocols, claims, and safety caveats.
A dedicated analysis of warnings, limitations, trade-offs, weak evidence, and uncertainty.
Repeatable methods, frameworks, mental models, processes, and systems.
A comprehensive extraction focused on opportunities, strategy, markets, and company building.
A concise first-pass summary for understanding the episode quickly.
A detailed readable summary organized by chapter or topic.
A navigable map of subjects, topic flow, and suggested chapters.
A comprehensive, source-grounded extraction of the reusable knowledge in an episode.
Reusable atomic knowledge units extracted from the episode.
A comprehensive extraction focused on health practices, protocols, claims, and safety caveats.
A comprehensive extraction focused on opportunities, strategy, markets, and company building.
Explicit actions, next steps, habits, recommendations, and things to avoid.
A dedicated inventory of concrete resources named in the episode.
A dedicated analysis of warnings, limitations, trade-offs, weak evidence, and uncertainty.
A concise first-pass summary for understanding the episode quickly.
A detailed readable summary organized by chapter or topic.
A navigable map of subjects, topic flow, and suggested chapters.
A comprehensive, source-grounded extraction of the reusable knowledge in an episode.
Reusable atomic knowledge units extracted from the episode.
A comprehensive extraction focused on health practices, protocols, claims, and safety caveats.
A comprehensive extraction focused on opportunities, strategy, markets, and company building.
Scientific findings, mechanisms, studies, hypotheses, and the limits of the evidence discussed.
Technologies, AI models, technical methods, capabilities, limitations, and adoption implications.
Investment theses, assets, catalysts, valuation reasoning, time horizons, and risks.
Chronologies, actors, causes, consequences, turning points, and competing historical interpretations.
Policies, proposals, stakeholders, arguments, implementation constraints, and predicted effects.
Career paths, skills, hiring signals, workplace decisions, transitions, and limitations of the advice.
Behavioral mechanisms, biases, motivation, habits, emotions, interventions, and evidence limitations.
Economic mechanisms, incentives, indicators, market structure, forecasts, and uncertainty.
Leadership principles, team systems, organizational design, culture, feedback, and failure modes.
Audience, positioning, messaging, acquisition, retention, experiments, metrics, and failed approaches.
Teaching methods, learning strategies, practice, feedback, assessment, and effectiveness evidence.
Theses, premises, arguments, objections, values, thought experiments, and unresolved questions.
Communication patterns, conflict, boundaries, expectations, repair methods, and contextual limitations.
Books, papers, authors, courses, and other learning resources mentioned in the episode.
Repeatable methods, frameworks, mental models, processes, and systems.
Explicit actions, next steps, habits, recommendations, and things to avoid.
Memorable statements and important claims with attribution and source context.
A dedicated inventory of concrete resources named in the episode.
A dedicated analysis of warnings, limitations, trade-offs, weak evidence, and uncertainty.